HALEOSLABS logo

Haleos Labs Limited Stock Price

NSEI:HALEOSLABS Community·₹4.7b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

HALEOSLABS Share Price Performance

₹1,552.30
353.50 (29.49%)
₹1,552.30
353.50 (29.49%)
Price ₹1,552.30

HALEOSLABS Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet and good value.

3 Risks
1 Reward

Haleos Labs Limited Key Details

₹3.3b

Revenue

₹2.0b

Cost of Revenue

₹1.3b

Gross Profit

₹1.1b

Other Expenses

₹173.1m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
57.26
38.60%
5.19%
47.4%
View Full Analysis

About HALEOSLABS

Founded
1990
Employees
592
CEO
Talluri Veera Venkata Murthy
WebsiteView website
haleoslabs.com

Haleos Labs Limited engages in the manufacturing of active pharmaceutical ingredients (API) and intermediates in India. The company offers API and intermediates in areas, such as anti-ulcer, anti-migraine, anti-hypertensive, erectile dysfunction, anti-cancer, antifungal, anti-obesity, anti-emetic, anti-depressant, anti-worm, anti-infective, anti-gout, anti-convulsant, antiviral, and anesthesia, as well as antihistamine, diuretics, hair loss, and ophthalmic API products. It also exports its products. The company was formerly known as SMS Lifesciences India Limited and changed its name to Haleos Labs Limited in August 2025. Haleos Labs Limited was founded in 1990 and is based in Hyderabad, India.

Recent HALEOSLABS News & Updates

Recent updates

No updates